AbbVie announced earnings per share of $2.34 on revenue of $10.43B. Analysts polled by Investing.com anticipated EPS of $2.2 on revenue of $9.93B.
AbbVie shares are up 8% from the beginning of the year , still down 5.17% from its 52 week high of $101.28 set on July 17. They are outperforming the S&P 500 which is up 0.48% from the start of the year.
AbbVie shares gained 2.25% in pre-market trade following the report.
AbbVie’s report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar